Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine.

ABSTRACT: Prostate cancer (PCa) is, with an estimated number of 161,360 cases and 26,730 deaths in 2017, the most common malignancy in the USA [...].

SUBMITTER: Stephan C 

PROVIDER: S-EPMC5666874 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature